Organ Preservation Solution Market Size & Growth Forecast 2027–2036, By Segments (End-user, Solution, Preservation Type, Organ), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Organ Preservation Solution Market size was around USD 320.64 Million in 2026 and is slated to grow at 7.21% CAGR from 2027 to 2036, crossing USD 643.24 Million by 2036. The industry revenue for 2027 is assessed at USD 340.26 Million.
Get more details on this report
Request Free Sample ReportOrgan Preservation Solution Market Intelligence Snapshot
Regional Market Dynamics
- North America held 42.61% in 2026, backed by advanced healthcare infrastructure, established transplantation systems, and continued investment in preservation technologies and clinical capabilities.
- Asia Pacific is the fastest-growing region as transplantation capabilities, specialized medical facilities, healthcare expenditure, and organ donation networks continue to expand.
Segment Momentum
- Organ transplant centers held a 55.54% market share in 2026 and remained the fastest-growing end-user segment due to high transplant volumes and strong demand for reliable preservation solutions that improve transplant outcomes.
- Normothermic machine perfusion is the fastest-growing preservation type because it maintains organs under near-physiological conditions, enables continuous organ assessment, and supports the use of more donor organs before transplantation.
Market Expansion Drivers
- Rising organ transplantation procedures increasing demand for advanced preservation solutions globally
- Growing healthcare infrastructure investments improving transplant program capacity and organ storage systems
- Expanding critical care transport networks driving need for portable organ preservation technologies
Leading Market Participants
- Major companies in the organ preservation solution market include TransMedics, Inc. (United States), XVIVO Perfusion AB (Sweden), Paragonix Technologies, Inc. (United States), OrganOx Limited (United Kingdom), Waters Medical Systems LLC (United States), Preservation Solutions, Inc. (United States), Dr. Franz Köhler Chemie GmbH (Germany), Accord Healthcare Inc. (United Kingdom), Bridge to Life Ltd. (United States), Shanghai Genext Medical Technology (China)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 320.64 Million
- 2027 Estimated Market Size: USD 340.26 Million
- Projected Market Size: USD 643.24 Million by 2036
- Growth Forecast: 7.21% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Organ Transplant Centers (End-user) | University of Wisconsin Solution (UW) (Solution) | Static Cold Storage (Preservation Type) | Kidneys (Organ)
- Emerging Opportunity Segment: Organ Transplant Centers (End-user) | University of Wisconsin Solution (UW) (Solution) | Normothermic Machine Perfusion (Preservation Type) | Kidneys (Organ)
Market Growth Drivers and Industry Trends
Rising organ transplantation procedures increasing demand for advanced preservation solutions globally
Increasing transplantation activity across healthcare systems is creating greater requirements for reliable methods that maintain organ quality between retrieval and implantation. The organ preservation solution market growth is driven by rising demand for advanced preservation formulations that support cellular stability, reduce preservation-related damage, and improve outcomes during transplant procedures. Transplant centers are increasingly adopting optimized solutions to extend organ viability and enhance coordination between donor availability and recipient readiness.
Growing healthcare infrastructure investments improving transplant program capacity and organ storage systems
Healthcare infrastructure expansion is strengthening transplant capabilities by enabling more hospitals and specialized centers to establish advanced organ handling and storage facilities. The organ preservation solution market growth is supported by investments in transplant program development, as improved clinical infrastructure increases the need for effective preservation systems throughout the organ procurement and storage process. Enhanced medical facilities are facilitating broader access to transplantation services and supporting the adoption of sophisticated preservation technologies.
Expanding critical care transport networks driving need for portable organ preservation technologies
Advancements in medical transport systems are increasing the importance of technologies that allow safe movement of donor organs across longer distances and complex logistics networks. The organ preservation solution market demand is rising as critical care transportation requires portable and efficient preservation approaches that maintain organ functionality during transfer. Improved mobility solutions are helping transplant teams manage time-sensitive procedures while reducing challenges associated with organ transportation.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising organ transplantation procedures increasing demand for advanced preservation solutions globally | 2% | High | North America, Europe | High | Near Term |
| Growing healthcare infrastructure investments improving transplant program capacity and organ storage systems | 1.8% | High | Asia Pacific, Latin America | Medium | Mid Term |
| Expanding critical care transport networks driving need for portable organ preservation technologies | 1.5% | Moderate | Europe, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the organ preservation solution market, North America held the largest share of 42.61% in 2026, supported by advanced healthcare infrastructure, sophisticated transplantation capabilities, and established organ donation and preservation systems. The region’s strong clinical ecosystem facilitates the adoption of advanced preservation approaches designed to maintain organ viability during transportation and before transplantation. Increasing emphasis on improving transplantation outcomes and optimizing the utilization of available donor organs is also supporting demand for effective preservation solutions. Continued healthcare investment and technological progress in transplantation practices further reinforce North America’s leading position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to emerge as the fastest-growing region, driven by improvements in healthcare infrastructure, expanding transplantation capabilities, and increasing awareness of organ donation. The development of specialized medical facilities across emerging healthcare markets is improving access to transplantation procedures and creating greater demand for reliable organ preservation technologies. Rising healthcare expenditure and efforts to strengthen organ donation and transplantation networks are further supporting market expansion. As healthcare systems increasingly adopt advanced medical technologies, opportunities for more effective preservation solutions are expected to broaden across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Transplant Innovation FocusThe U.S. emphasizes advanced organ preservation solutions that support expanding transplant programs and improve organ viability across long transport distances. Hospitals and research institutions continue evaluating preservation technologies that enhance clinical workflows and transplant outcomes.
Germany 🇩🇪
Clinical Quality IntegrationGermany prioritizes organ preservation solutions that align with stringent transplant quality standards and hospital efficiency requirements. The country continues adopting advanced preservation practices that support reliable organ handling across established transplant centers.
Japan 🇯🇵
Precision Preservation PracticesJapan focuses on organ preservation solutions that complement high clinical standards and careful transplant management. Japanese healthcare providers increasingly evaluate preservation methods that extend organ usability while supporting consistent procedural outcomes.
South Korea 🇰🇷
Advanced Transplant SupportSouth Korea is strengthening the adoption of organ preservation solutions through investments in transplant capabilities and hospital modernization. The country supports technologies that improve organ handling efficiency and facilitate broader clinical utilization.
France 🇫🇷
Hospital Transplant OptimizationFrance integrates organ preservation solutions into established transplant networks with an emphasis on maintaining organ quality throughout procurement and transport. French healthcare providers continue refining preservation protocols to support clinical consistency.
Italy 🇮🇹
Preservation Workflow EnhancementItaly focuses on improving transplant efficiency through reliable organ preservation solutions that support coordination among regional transplant centers. The country encourages technologies that enhance storage stability and streamline clinical logistics.
Segment Leadership and Growth Trends
Organ Preservation Solution Market Share (%), by End-user, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-user Segment Analysis: Organ Transplant Centers (Largest & Fastest-Growing Segment)
The organ transplant centers segment dominated the organ preservation solution market, accounting for 55.54% of the market share in 2026 while also emerging as the fastest-growing end-user segment. These specialized centers perform a high volume of transplant procedures and require reliable preservation solutions to maintain organ viability throughout retrieval, transportation, and transplantation. Continuous advances in transplant techniques, increasing donor organ utilization, and the growing focus on improving transplant outcomes are driving sustained demand for high-performance preservation solutions within dedicated transplant facilities.
Solution Segment Analysis: University of Wisconsin Solution (UW) (Largest & Fastest-Growing Segment)
The university of wisconsin solution (UW) segment held the largest share of 41.26% in 2026 and is also expected to remain the fastest-growing solution segment. Its widespread adoption is supported by its proven effectiveness in preserving donor organs by minimizing cellular injury and maintaining tissue integrity during cold storage. The solution has become a preferred choice for preserving multiple organ types because it supports longer preservation periods and contributes to improved transplant success, reinforcing its importance in modern organ transplantation practices.
Preservation Type Segment Analysis: Static Cold Storage (Largest Segment) vs Normothermic Machine Perfusion (Fastest-Growing Segment)
Static cold storage accounted for the largest share in 2026 owing to its long-standing clinical acceptance, operational simplicity, and broad compatibility with established organ transplantation protocols. The technique remains widely used because it offers a practical and cost-effective method for preserving donor organs during transportation while requiring relatively straightforward equipment and handling procedures.
Normothermic machine perfusion is expected to witness the fastest growth as transplant programs increasingly adopt advanced preservation technologies that maintain organs under near-physiological conditions before transplantation. The approach enables continuous assessment of organ function, supports improved preservation quality, and expands opportunities to utilize donor organs that may previously have been considered unsuitable, contributing to greater adoption across transplant centers.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-user | Organ Transplant Centers, Hospitals, Others | Organ Transplant Centers | Organ Transplant Centers |
| Solution | University of Wisconsin Solution (UW), Custodiol HTK Solution, Perfadex Solution, Steen Solution, Celsior Solution, Hypothermosol Solution, Others | University of Wisconsin Solution (UW) | University of Wisconsin Solution (UW) |
| Preservation Type | Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion | Static Cold Storage | Normothermic Machine Perfusion |
| Organ | Kidneys, Liver, Lungs, Heart, Others | Kidneys | Kidneys |
Competitive Landscape and Market Positioning
Leading companies in the organ preservation solution market:
- TransMedics, Inc. (United States)
- XVIVO Perfusion AB (Sweden)
- Paragonix Technologies, Inc. (United States)
- OrganOx Limited (United Kingdom)
- Waters Medical Systems LLC (United States)
- Preservation Solutions, Inc. (United States)
- Dr. Franz Köhler Chemie GmbH (Germany)
- Accord Healthcare, Inc. (United Kingdom)
- Bridge to Life Ltd. (United States)
- Shanghai Genext Medical Technology (China)
Clinical expectations for improved transplant outcomes are reshaping competition in the organ preservation solution market, encouraging developers to pursue formulations tailored to specific organ types and increasingly complex transplantation procedures. Innovation is extending beyond preservation chemistry to encompass compatibility with advanced preservation techniques and evolving clinical workflows, creating differentiation through broader procedural support rather than incremental formulation changes alone. Regulatory rigor and the need for consistent manufacturing quality are reinforcing barriers to entry, while transplant centers are placing greater value on preservation technologies supported by reliable clinical performance across diverse operating conditions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| TransMedics Inc. (United States) | |||||||
| XVIVO Perfusion AB (Sweden) | |||||||
| Paragonix Technologies Inc. (United States) | |||||||
| OrganOx Limited (United Kingdom) | |||||||
| Waters Medical Systems LLC (United States) | |||||||
| Preservation Solutions Inc. (United States) | |||||||
| Dr. Franz Köhler Chemie GmbH (Germany) | |||||||
| Accord Healthcare Inc. (United Kingdom) | |||||||
| Bridge to Life Ltd. (United States) | |||||||
| Shanghai Genext Medical Technology (China) |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Organ Preservation Solution Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Donor Type | Donation After Brain Death, Donation After Circulatory Death, Living Donors |
| Distribution Channel | Direct Sales, Specialty Distributors, Online & Institutional Procurement |
| Transplant Workflow Stage | Organ Retrieval, Organ Transportation, Pre-Transplant Preparation |
Organ Preservation Solution Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Preservation Technology Adoption Landscape |
|
| Transplant Center Procurement Benchmarking |
|
| Transplant Program Funding and Reimbursement |
|
Need a different cut of the data?
Request Custom ResearchHow large is the organ preservation solution market?
What is the anticipated CAGR of the organ preservation solution industry?
How is rising transplantation activity influencing demand for organ preservation solutions?
Why are healthcare infrastructure investments supporting growth in the organ preservation solution market?
Why do organ transplant centers dominate the organ preservation solution market?
Which preservation type is experiencing the fastest growth in the organ preservation solution market?
What supports North America's leadership in organ preservation solutions?
How is Asia Pacific creating new opportunities for organ preservation solutions?
Who holds a significant market share in the organ preservation solution landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization